Close Menu

Data Sharing Works

Seven years ago, NIH, FDA, researchers from industry, academia, and some nonprofit groups got together to find biomarkers for Alzheimer's disease. Now, the New York Times' Gina Kolata says the collaboration has resulted in several papers on early diagnosis of Alzheimer's using PET scans and spinal fluid tests, and more than 100 drug studies in progress. The key to the project, Kolata says, is the data sharing aspect.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.